Julie Anne Smith
DirectoratStoke Therapeutics· In proxies 2023–2025
Julie Anne Smith sits on 3 public boards.
Experience
- Stoke TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +222%
- Exelixis, Inc.Public company
- Director? – PresentNo stock prices for these years
- Audentes Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- HealthPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?